Author Correction: AHR is a Zika virus host factor and a candidate target for antiviral therapy.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 12 8 2020
medline: 12 8 2020
entrez: 12 8 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32778795
doi: 10.1038/s41593-020-0700-0
pii: 10.1038/s41593-020-0700-0
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1307

Commentaires et corrections

Type : ErratumFor

Auteurs

Federico Giovannoni (F)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Laboratorio de Estrategias Antivirales, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. CONICET-Instituto de Química Biológica, Buenos Aires, Argentina.

Irene Bosch (I)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.

Carolina Manganeli Polonio (CM)

Neuroimmune Interactions Laboratory, Immunology Department-ICB IV, University of São Paulo, São Paulo, Brazil.
Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil.

María F Torti (MF)

Laboratorio de Estrategias Antivirales, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. CONICET-Instituto de Química Biológica, Buenos Aires, Argentina.

Michael A Wheeler (MA)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Zhaorong Li (Z)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Leonardo Romorini (L)

Laboratorio de Investigación aplicada a Neurociencias, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Buenos Aires, Argentina.

María S Rodriguez Varela (MS)

Laboratorio de Investigación aplicada a Neurociencias, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Buenos Aires, Argentina.

Veit Rothhammer (V)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Andreia Barroso (A)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Emily C Tjon (EC)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Liliana M Sanmarco (LM)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Maisa C Takenaka (MC)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Seyed Mohamad Sadegh Modaresi (SMS)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Cristina Gutiérrez-Vázquez (C)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Nágela Ghabdan Zanluqui (NG)

Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil.
Immunopathology and Allergy Post Graduate Program, School of Medicine, University of São Paulo, São Paulo, Brazil.

Nilton Barreto Dos Santos (NB)

Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.

Carolina Demarchi Munhoz (CD)

Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.

Zhongyan Wang (Z)

Dept. of Environmental Health, Boston University School of Public Health, Boston, MA, USA.

Elsa B Damonte (EB)

Laboratorio de Estrategias Antivirales, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. CONICET-Instituto de Química Biológica, Buenos Aires, Argentina.

David Sherr (D)

Dept. of Environmental Health, Boston University School of Public Health, Boston, MA, USA.

Lee Gehrke (L)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Jean Pierre Schatzmann Peron (JPS)

Neuroimmune Interactions Laboratory, Immunology Department-ICB IV, University of São Paulo, São Paulo, Brazil. jeanpierre@usp.br.
Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil. jeanpierre@usp.br.
Immunopathology and Allergy Post Graduate Program, School of Medicine, University of São Paulo, São Paulo, Brazil. jeanpierre@usp.br.

Cybele C Garcia (CC)

Laboratorio de Estrategias Antivirales, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. CONICET-Instituto de Química Biológica, Buenos Aires, Argentina. cygarcia@qb.fcen.uba.ar.

Francisco J Quintana (FJ)

Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.
Broad Institute of MIT and Harvard, Cambridge, MA, USA. fquintana@rics.bwh.harvard.edu.

Classifications MeSH